-

List of publications

1. (conference) Volpina OM, Kamynina AV, Koroev DO, Volkova TD, Filatova MP, Samokhin A, Bobkova N (2019). Neuroprotective activity of the (60-76) rage fragment and its protected analogue in tg animal model of Alzheimer’s disease. 14th​ International Conference on Alzheimer's and Parkinson's Diseases ,
2. Avetisyan A, Balasanyants S, Simonyan R, Koroev D, Kamynina A, Zinovkin R, Bobkova N, Volpina O (2020). Synthetic fragment (60-76) of RAGE improves brain mitochondria function in olfactory bulbectomized mice. Neurochem Int 140, 104799
3. Koroev DO, Volpina OM, Volkova TD, Kamynina AV, Samokhin AN, Filatova MP, Bobkova NV (2019). A Synthetic Fragment of the Receptor for Glycation End Products and Its Analogue Improve Memory in Transgenic Alzheimer’s Disease Mouse Model. Russ. J. Bioorganic Chem. 45 (5), 361–365
4. Kamynina A, Esteras N, Koroev DO, Angelova PR, Volpina OM, Abramov AY (2021). Activation of RAGE leads to the release of glutamate from astrocytes and stimulates calcium signal in neurons. J Cell Comp Physiol 236 (9), 6496–6506
5. Volpina OM, Koroev DO, Serebryakova MV, Volkova TD, Kamynina AV, Bobkova NV (2021). Proteolytic degradation patterns of the receptor for advanced glycation end products peptide fragments correlate with their neuroprotective activity in Alzheimer's disease models. Drug Dev Res 82 (8), 1217–1226